Literature DB >> 10228778

Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

R Olsson1, U Broomé, A Danielsson, I Hägerstrand, G Järnerot, L Lööf, H Prytz, B O Rydén.   

Abstract

An analysis was made of the symptom diaries of 65 patients with primary sclerosing cholangitis (PSC) who recorded their symptoms of itching, pain and fever during a 3 year period. Symptoms occurred in 84% of the patients, with considerable individual variations in symptom load. Symptoms were usually intermittent. "Itching only" and "pain only" were the most frequent episode features. Most episodes lasted only 1-2 days. Fever seemed to be the most embarrassing symptom. Apart from close correlations between pruritus and serum ALP levels, there were no significant correlations between the symptom load and serum biochemistry or eleven different histological features. Even daily symptoms over a period of several months could disappear spontaneously. We conclude that most symptom episodes in PSC are mono-symptomatic and brief. Biochemical or histological data do not predict the appearance of symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228778

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis.

Authors:  Peter P Stanich; Einar Björnsson; Andrea A Gossard; Felicity Enders; Roberta Jorgensen; Keith D Lindor
Journal:  Dig Liver Dis       Date:  2011-01-19       Impact factor: 4.088

Review 2.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

3.  Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.

Authors:  H O Nilsson; J Taneera; M Castedal; E Glatz; R Olsson; T Wadström
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 4.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

5.  Gallbladder emptying in patients with primary sclerosing cholangitis.

Authors:  Karouk Said; Nick Edsborg; Nils Albiin; Annika Bergquist
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

6.  Small-duct primary sclerosing cholangitis.

Authors:  Einar Björnsson
Journal:  Curr Gastroenterol Rep       Date:  2009-02

7.  Searching for Bacterial Biofilm in Recurrent Cholangitis in Primary Sclerosing Cholangitis: A Case Presentation and Introduction of an Unexplored Disease Mechanism.

Authors:  Alyssa Y Choi; Florencia Jalikis; Maria Westerhoff; Sarag Boukhar; Elinor Pulcini; Chris Damman; Lei Yu
Journal:  J Clin Transl Hepatol       Date:  2017-12-17

Review 8.  Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Authors:  Melissa Palmer; Arie Regev; Keith Lindor; Mark I Avigan; Lara Dimick-Santos; William Treem; John F Marcinak; James H Lewis; Frank A Anania; Daniel Seekins; Benjamin L Shneider; Naga Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2019-11-25       Impact factor: 8.171

9.  Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study.

Authors:  Bertus Eksteen; Christopher L Bowlus; Aldo J Montano-Loza; Eric Lefebvre; Laurent Fischer; Pamela Vig; Eduardo Bruno Martins; Jawad Ahmad; Kidist K Yimam; Paul J Pockros; Jordan J Feld; Gerald Minuk; Cynthia Levy
Journal:  Hepatol Commun       Date:  2020-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.